HTG Molecular Diagnostics, Inc. Appoints Christopher P. Kiritsy to Serve as Class I Director, Member of Audit Committee

on January 27, 2022, the Board of Directors of HTG Molecular Diagnostics, Inc. upon recommendation of the Nominating and Governance Committee of the Board (the “Nominating Committee”), appointed Christopher P. Kiritsy to serve as a Class I director of the Company, with a term expiring at the Company's annual meeting of stockholders to be held in 2022. The Board also appointed Mr. Kiritsy to serve on the Audit Committee.